TORNTPHARM.NSTORNTPHARM.NS
LOADING
|||
Cash Flow Under Pressure
Trending lower, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$19.74B
↑ 34% above average
Average (9y)
$14.74B
Historical baseline
Range
High:$28.33B
Low:$1.03B
CAGR
-0.7%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2025 | $19.74B | -30.3% |
| 2024 | $28.33B | +57.9% |
| 2023 | $17.94B | +12.1% |
| 2022 | $16.00B | -4.5% |
| 2021 | $16.76B | +70.1% |
| 2020 | $9.85B | -13.2% |
| 2019 | $11.35B | +1002.9% |
| 2018 | $1.03B | -80.4% |
| 2017 | $5.26B | -75.1% |
| 2016 | $21.09B | - |